Fort Sheridan Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,700
Closed -$212K 257
2024
Q3
$212K Hold
5,700
0.03% 234
2024
Q2
$271K Buy
+5,700
New +$250K 0.04% 197
2023
Q3
Sell
-4,700
Closed -$247K 205
2023
Q2
$247K Buy
4,700
+1,000
+27% +$60.9K 0.06% 164
2023
Q1
$237K Buy
+3,700
New +$241K 0.06% 170
2022
Q4
Sell
-3,700
Closed -$261K 188
2022
Q3
$261K Hold
3,700
0.09% 149
2022
Q2
$262K Hold
3,700
0.09% 149
2022
Q1
$296K Hold
3,700
0.09% 145
2021
Q4
$338K Hold
3,700
0.1% 138
2021
Q3
$476K Sell
3,700
-100
-3% -$14K 0.16% 107
2021
Q2
$580K Sell
3,800
-400
-10% -$52.7K 0.19% 92
2021
Q1
$443K Buy
+4,200
New +$421K 0.18% 87
2019
Q1
Sell
-135,000
Closed -$4.31M 102
2018
Q4
$4.31M Buy
+135,000
New +$5.26M 3.05% 8

Other funds holding STAA

Fort Sheridan Advisors's STAA Position: Q4 2024 in Review

Fort Sheridan Advisors sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 5,700 shares — an estimated $212K sold.

Fort Sheridan Advisors first reported a position in STAA in Q4 2018 and held it in 12 quarters. The position peaked at $4.31M in Q4 2018. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

  • Fort Sheridan Advisors reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
  • Fort Sheridan Advisors sold 5,700 STAAR Surgical shares in Q4 2024, an estimated $212K.
  • Fort Sheridan Advisors first reported a position in STAAR Surgical in Q4 2018 and held it in 12 quarters.
  • Fort Sheridan Advisors's STAAR Surgical position peaked at $4.31M in Q4 2018.
  • 212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on Fort Sheridan Advisors's 13F filing for Q4 2024, filed 5 Feb 2025.